MARKET

CLSN

CLSN

Celsion
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.260
+0.180
+16.67%
Pre Market: 1.210 -0.05 -3.97% 06:45 08/05 EDT
OPEN
1.150
PREV CLOSE
1.080
HIGH
1.330
LOW
1.080
VOLUME
8.29M
TURNOVER
--
52 WEEK HIGH
6.50
52 WEEK LOW
0.6865
MARKET CAP
40.22M
P/E (TTM)
-1.4723
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average CLSN stock price target is 6.00 with a high estimate of 9.00 and a low estimate of 4.000.

EPS

CLSN News

More
Celsion up 10% on ray of hope for ThermoDox in liver cancer study
Nano cap Celsion (NASDAQ:CLSN) is up 10% premarket on increased volume in reaction to its announcement that will continue following patients for overall su
seekingalpha · 16h ago
Celsion Corporation To Continue Following Patients In Phase III OPTIMA Study For Overall Survival
Ongoing Analysis of Unblinded Study Data Suggests Data Maturity May be at Issue Cohort of 26 Consecutive Patient Deaths Differs Substantially from Predicted Behavior and from the Balance of the Trial LAWRENCEVILLE,
Benzinga · 22h ago
Celsion Corporation to Continue Following Patients in Phase III OPTIMA Study for Overall Survival
Ongoing Analysis of Unblinded Study Data Suggests Data Maturity May be at Issue Cohort of 26 Consecutive Patient Deaths Differs Substantially from Predicted Behavior and from the Balance of the Trial LAWRENCEVILLE, N.J., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Celsi
GlobeNewswire · 22h ago
Celsion Trial Progress, And Other News: The Good, Bad And Ugly Of Biopharma
Seeking Alpha · 07/28 19:53
Celsion initiates mid-stage GEN-1 study in ovarian cancer
Seeking Alpha · 07/27 14:22
Celsion Corporation Initiates Phase II OVATION 2 Study of GEN-1 in Advanced Ovarian Cancer
Promising Translational and Clinical Findings Support the Randomized Trial in Newly Diagnosed Patients Non-Viral Nanoparticle Delivery System, TheraPlas Platform, Demonstrates Potential for Long-Term, Repeat Administration Up To 6 MonthsLAWRENCEVILLE, N.J.,
GlobeNewswire · 07/27 12:30
Is the Options Market Predicting a Spike in Celsion (CLSN) Stock?
Investors need to pay close attention to Celsion (CLSN) stock based on the movements in the options market lately.
Zacks · 07/21 12:56
Celsion (CLSN) Stock Loses a Wall Street Supporter
Stocks go up, stocks go down, you can't explain that...Or maybe you can, if the stock happen to be a biotech that just flunked a clinical trial. Which leads us nicely to Celsion Corporation (CLSN). Or not so nicely if you happen to be an investor.Shares crater
SmarterAnalyst · 07/18 02:26

Industry

Biotechnology & Medical Research
+0.02%
Pharmaceuticals & Medical Research
-0.36%

Hot Stocks

Symbol
Price
%Change

About CLSN

Celsion Corporation is an oncology drug development company. The Company's product candidate is ThermoDox, a heat-activated liposomal encapsulation of doxorubicin, which is in Phase III clinical trial for treatment of primary liver cancer (the OPTIMA Study) and a Phase II clinical trial for treatment of recurrent chest wall breast cancer (the DIGNITY Study). Its pipeline also includes GEN-1, a deoxyribonucleic acid (DNA) mediated immunotherapy for the localized treatment of ovarian and brain cancers. It has over three platform technologies for the development of treatments for those suffering with difficult-to-treat forms of cancer, including Lysolipid Thermally Sensitive Liposomes, a heat sensitive liposomal based dosage form that targets disease with known therapeutics in the presence of mild heat; TheraPlas, a nucleic acid-based treatment for local transfection of therapeutic plasmids, and TheraSilence, a systemic dosage form for lung directed anti-cancer ribonucleic acid (RNA).
More

Webull offers kinds of Celsion Corporation stock information, including NASDAQ:CLSN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CLSN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CLSN stock methods without spending real money on the virtual paper trading platform.